Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients

Case Reports in Immunology - United States
doi 10.1155/2018/8067610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Urticaria and Angioedema as Possible Reactions of Omalizumab

Anais Brasileiros de Dermatologia
Dermatology
2018English

Increasing Evidence for Omalizumab in the Treatment of Bullous Pemphigoid

JAAD Case Reports
Dermatology
2020English

Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Effectiveness of Omalizumab in Adolescent and Adult Patients With Chronic Idiopathic/Spontaneous Urticaria: A Systematic Review of “Real-World” Evidence

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2018English

Idiopathic Intestinal Angioedema: A Diagnostic Dilemma

Cureus
2019English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Response to H1 Antihistamine Therapy in Idiopathic Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab Response in Patients With Chronic Idiopathic Urticaria: Insights From the XTEND-CIU Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy